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Abstract 
Objective: To document the prevalence, age and gender distribution of oral lesions in HIV infected adults and the 
influence of highly active antiretroviral therapy and correlate them to the immune status of the patients.
Materials and Methods: Oral lesions were diagnosed by a detailed physical examination by trained and calibrated 
examiners according to the case definitions established by the Oral HIV/AIDS research alliance. Demographic 
details, risk behavior patterns and oral symptoms and habits were collected by a questionnaire.
Results: 81 patients; 54 men and 27 women aged between 20 – 55 years participated in the study. A total of 49 
patients; 60.5% had some oral lesion when examined. Oral candidiasis (21 %) and oral melanosis (21%) were the 
most common lesions, followed by linear gingival erythema, oral hairy leukoplakia, necrotizing ulcerative perio-
dontitis/gingivitis, herpes labialis, parotid gland enlargement and reccurent apthous ulcers.  Oral hairy leukoplakia 
was exclusively seen in men (p=0.018).   All six cases of herpes simplex lesion were seen in non - anti retro viral 
group (p=0.073) while oral candidiasis was commonly noted in the anti retro viral group (p=0.073). Lowering CD4 
counts had the strongest association with the prevalence of oral candidasis (p=0.012), pseudomembranous candi-
diasis (p=0.014) and oral hairy leukoplakia (p= 0.065). 
Conclusion: This study shows a high prevalence of oral candidiasis, melanosis, linear gingival erythema and oral 
hairy leukoplakia in the patients.
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Introduction
Acquired Immunodeficiency Syndrome (AIDS) has 
emerged as a global crisis since its discovery in 1981 
with the epicenter now firmly located in Asia and Africa 
(1). Nepal, home to some 23 million people has more 
than a hundred ethnic and linguistic groups (2). A decade 
long armed conflict here has had a tremendous repercus-
sion on the overall development in the country adding to 
poverty, deprivation and discrimination. In this period, 
the Human Immunodeficiency Virus (HIV) status has 
evolved from a “low” to a “concentrated” epidemic (3) 
after the first case of AIDS here was reported in 1988. As 
of 2011, national estimates indicate that approximately 
50,200 adults and children are infected with HIV with a 
probable overall prevalence of about 0.30% in the adult 
population (15-49 years old)(4). The epidemic in Nepal 
is driven by injecting drug use and heterosexual trans-
mission (5). The highest burden of the epidemic is sha-
red by the highway districts (Terai region) where nearly 
50% people with HIV are living (4). The scarcity of re-
ports on the oral manifestations of HIV from the eastern 
region of the highway districts (Eastern Terai) helped 
conceive the present study. In this context, we studied 
the clinical presentations, prevalence, age & gender dis-
tribution of oral lesions and the influence of anti-retro 
viral (ARV) therapy in HIV sero-positive adult patients 
in eastern Nepal and correlated these parameters to their 
immune status.
Material and Methods
A total of 81 adult patients with HIV infection/AIDS 
comprised the sample for the cross-sectional study. The 
patients were either attending the out patient clinic of the 
departments of Tropical diseases and General medicine 
or were directly recruited from 6 HIV rehabilitation cen-
tres in eastern Nepal. The study was conducted during 
a period of 5 months, from June 2008 to October 2008. 
The study had the approval of the research committee of 
the institution and the informed consent of the participa-
ting patients’. 
HIV serology of all patients was performed at the cen-
tral laboratory of our institution and included the en-
zyme-linked immunosorbent assays (HIV Tri-dot Test, 
J.Mitra Co, India and HIV ELISA, Merind Diagnostics, 
Belgium). Two separate positive tests were considered 
confirmatory in all cases. All patients were evaluated for 
CD4 T- lymphocyte counts [Fluorescence-Activated Cell 
Sorter Count (FACS) machine BD Biosciences FACS 
count SW 1.5/4/05] after staining patient’s blood with 
monoclonal antibodies.  Patients were examined within 
one month of obtaining the CD4 lymphocyte counts. A 
short questionnaire was used to collect data on demogra-
phic details, risk behavior patterns and oral deleterious 
habits. Details of drugs taken were retrieved from the 
medical records of the patients. 
The physical examination was carried out by a specia-
list in Oral Medicine and either of two dental surgeons. 
The examiners were trained and calibrated on ten HIV/
AIDS patients with multiple oral lesions. The examiners 
were neither aware of the HIV clinical stage and the 
CD4 cell count nor whether the patient was on anti-retro 
viral (ARV) therapy or not. A standard oral examination 
recommended by World Health Organization (WHO) 
was followed under artificial light. The extra oral and 
peri-oral tissues were examined first followed by intra 
oral tissues for changes in size, color and shape of ana-
tomical areas as well as for clinical signs and lesions. 
The oral lesions associated with HIV infection were 
diagnosed based on case definitions established by the 
Oral HIV/AIDS research alliance (6) and photographic 
records were made of the lesions.
Statistical Analysis
The data obtained were encoded, entered and analyzed 
using SPSS version 11.5. Patients were categorized by 
gender, clinical stage, age and ARV therapy. Prevalen-
ce of oral lesions in different groups and comparisons 
between groups of total sample were performed using 
the Chi Squared test. In situations where 5% of cells had 
expected count less than 5 Fisher’s exact test was used. 
Bivariate analysis by Spearman Rho’s rank correlations 
was used to find the association between CD4 counts 
and occurrence of lesions, influence of ARV therapy. 
A p-value of <0.05 was considered significant. Inter-
observer variability between examiners was assessed by 
Kappa statistic.
Results
The study included 54 men and 27 women (M: F ratio 
of 2:1) with a combined mean age for men and women 
at 32.493 years. The women were younger at a mean of 
30.25 years than the men at 33 years.  Majority of the 
patients 67(82.7%) were in the age group 20-39 years. 
The distribution of CD4 count between various groups 
is summarized in table 1.  The average CD4 counts were 
more in the women 379.70cells/cu mm than the men 
252.51 cells /cu mm. 
Mode of transmission is summarized in Fig. 1 and Fig. 2. 
About 31 patients; 38.3% indulged in injected drug use 
(IDU) and 25 patients; 30.9% had unsafe sexual contact 
with commercial sex workers within the past 5 years. 
Oral lesions of HIV/AIDS were seen in 49 patients; 
60.5% who included 32 men and 17 women. The num-
ber of oral lesions ranged from single to a maximum of 
4 per subject. The most common diagnosis was oral can-
didiasis [OC] (21 %) and oral melanosis[OM] (21%) fo-
llowed by linear gingival erythema[LGE] (17.3%), oral 
hairy leukoplakia[OHL] (12.3%), necrotizing ulcerative 
periodontitis/ginigvitis[NUP/NUG] (8.6%), herpes la-
bialis (7.4%), parotid gland enlargement [PGE] (3.7%) 
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Fig.1. Showing Distribution of patients based on mode of transmission of HIV infection.
Fig. 2. Showing distribution of patients based on unsafe sexual contact history preceding HIV infection.
Distribution 
in groups CD4 cell counts in various groups Statistical inference
Gender % N Mean CD4 count Std. Deviation Minimum Maximum F sig
Male 66.7 54 252.5185 152.65533 5.00 654.00
9.423 .003
Female 33.3 27 379.7037 215.37638 65.00 968.00
Stage
(CD4 >500)Stage A 11.1 9 649.7778 155.66131 504.00 968.00
161.034 .000(CD4 500-200)Stage B 48.1 39 354.7949 78.10795 204.00 492.00
(CD4<200)Stage C 40.7 33 127.3636 57.83534 5.00 200.00
ARV 
not taking 65.4 53 350.3396 192.40851 5.00 968.00
16.455 .000
taking 34.6 28 190.0000 111.59119 42.00 517.00
Age groups
20-29 37.0 30 416.2333 184.81168 168.00 968.00
9.349 .000
30-39 45.7 37 227.2973 143.46793 5.00 654.00
40-49 13.6 11 191.0000 140.14992 42.00 468.00
50-59 3.7 3 296.6667 193.52605 105.00 492.00
*CD4 [cluster of differentiation 4] - helper T lymphocyte,  ARV- Anti Retro Viral
Table 1. Showing the distribution of CD4* cell counts in gender, ARV therapy, disease stage & age groups.
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and reccurent apthous ulcers (1.2%). Other lesions ob-
served but not included in the HIV case definitions were 
leukoplakia (13 cases; 16%), tobacco pouch keratosis 
(10 cases; 12.3%) and lichenoid lesions (3 cases; 3.7%). 
The inter-observer agreement in the identification of oral 
lesions of HIV/AIDS was found to be 0.85 by Kappa 
statistics.
Table 2 shows distribution of oral lesions of HIV/AIDS 
by gender and ARV therapy. Thirty-two men had oral 
lesions as compared to 17 women. All 10 cases of OHL 
were seen exclusively in men (p=0.018). Fifty three pa-
tients; 65.4% had not received any anti retro viral thera-
py. Oral lesions of HIV /AIDS were seen in 19 patients; 
67.8% on ARV therapy as opposed to 44 patients; 83% 
not on ARV therapy. The most common oral lesion in pa-
tients’ on highly active anti retro viral therapy [HAART] 
was oral candidiasis (9 cases;32.1 %) and oral melano-
sis (9 cases;32.1%) followed by linear gingival erythe-
ma [LGE], oral hairy leukoplakia [OHL], erythematous 
candidiasis [EC], pseudomembranous candidiasis[PC] 
and necrotizing ulcerative periodontitis/ginigvitis [NUP/
NUG]. In the patients’ not on HAART, erythematous 
candidiasis (9 cases; 17%) was seen frequently followed 
by LGE, herpes labialis and OHL. All six cases of her-
pes simplex lesion were seen in non - anti retro viral 
group (p=0.073) while oral candidiasis was commonly 
noted in the anti retro viral group (p=0.073).
Distribution of oral lesions by stage of disease along with 
associations with CD4 counts are summarized in table 3. 
Pseudomembranous candidiasis was found to be exclu-
sive to stage C disease with CD4 counts < 200 cells/cu 
mm(p= 0.47).  Associations between falling CD4 counts 
and the increased prevalence of oral lesions was found 
to be strongest for OC (p=0.012), PC (p=0.014) and 
OHL (p= 0.065).
Discussion
Nepal’s recent history replete with political strife, armed 
conflict and poor development has allowed its progres-
sion from a “low” to a “concentrated” HIV epidemic 
status after the first case of AIDS here was reported in 
1988. The paucity of data on oral lesions in HIV infected 
adults from the Asian subcontinent and the multi eth-
nic nature of Nepal’s population makes comparison a 
challenge. Patients in our study were frequently men 54 
cases; 66.7% with an M: F ration of 2:1 as compared to 
the national average of 2.9:1.The average age of 32.49 
years was similar to other studies from the subcontinent 
(1). The peak age distribution of 20-39 years reflects the 
national data on HIV prevalence in Nepal. The largest 
number of HIV positive cases 42% was reported among 
men and women aged 30 to 39 years followed by 22% 
of 24 to 29 year olds. The anticipated decrease in wor-
king force could thereby have an adverse effect on the 
socioeconomic status of the country. 
Heterosexual contact in 37 cases; 45.7% closely fo-
llowed by injected drug use in 31 cases; 38.3% was the 
major route of transmission. This trend was seen in most 
Asian studies except the Thailand study (7) where in-
travenous drug users constituted the majority. Although 
Lesion TotalNo. (%)
Gender
λ2 Value sig
ARV
λ2 Value sigMale
No. (%)
Female
No. (%)
Not taking 
No. (%)
Taking 
No. (%)
1. One lesion 31(38.3) 21(38.9) 10(37) .329a .848 23(43.4) 9(32.1) 2.556a .279
2. Multiple lesions 18(22.2) 11(20.4) 7(25.9) - 21(39.6) 10(35.7) - -
3. Oral Candidiasis 17(21) 10(18.5) 7(25.9) .596a .440 8(15.1) 9(32.1) 3.211a .073
4. Pseudomembranous Candidiasis 4(4.9) 3(5.6) 1(3.7) .131a .717 1(1.9) 3(10.7) 3.041a .081
5. Erythematous Candidiasis 13(16) 8(14.8) 5(18.5) .183a .669 9(17) 4(14.3) .099a .753
6. Angular Cheilitis 1(1.2) 0 1(3.7) 2.025a .155 1(1.9) 0 .535a .465
7. Oral hairy leukoplakia 10(12.3) 10(18.5) 0 5.704a .017 6(11.3) 4(14.3) .149a .700
8. Oral Warts 0(0) 0(0) 0(0) - - 0(0) 0(0) - -
9. Herpes Labialis 6(7.4) 2(3.7) 4(14.8) 3.240a .072 6(11.3) 0 3.423a .064
10. Herpetic Ulcers 0(0) 0(0) 0(0) - - 0(0) 0(0) - -
11. LGE* 14(17.3) 9(16.7) 5(18.5) .043a .835 7(13.2) 7(25) 1.782a .182
12. NUP/NUG* 7(8.6) 5(9.3) 2(7.4) .078a .780 4(7.5) 3(10.7) .233a .629
13. Recurrent Apthous  Ulcers 1(1.2) 1(1.2) 0 .506a .477 1(1.9) 0 .535a .465
14. Ulcers NOS* 0(0) 0(0) 0(0) - - 0(0) 0(0) - -
15. Melanosis 17(21) 11(20.4) 6(22.2) .037a .847 8(15.1) 9(32.1) 3.211a .073
16. Parotid gland enlargement 3(3.7) 1(1.9) 2(7.4) 1.558a .212 2(3.8) 1(3.6) .002a .963
17. Xerostomia 0(0) 0(0) 0(0) - - 0(0) 0(0) -
18. Kaposis sarcoma 0(0) 0(0) 0(0) - - 0(0) 0(0) -
19. Oral SCC* 0(0) 0(0) 0(0) - 0(0) 0(0) - -
20. Non Hodgkin’s Lymphoma 0(0) 0(0) 0(0) - 0(0) 0(0) - -
*ARV- Anti Retro Viral, LGE- Linear Gingival Erythema,NUP/NUG- Necrotizing Ulcerative Periodontitis/Necrotizing Ulcerative Gingivitis, 
Ulcers NOS- Ulcers Not Otherwise Specified, Oral SCC – Oral Squamous Cell Carcinoma.
Tabe 2. Distribution of lesions by gender and ARV* therapy.
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men having sex with men (MSM) constitute 4% of the 
HIV infected patients from the national data (4) we did 
not find any such cases. 
Oral lesions of HIV/AIDS were seen in (49 cases; 60.5%) 
patients. However, previous studies in Thailand (82 %) 
(8), India (86%) (9) and Cambodia (90%)(10)have re-
ported a higher prevalence. The lesions ranged from 
a single to a maximum of 4 lesions per subject. CD4 
counts appeared to decrease with age (-0.403,p=0.000). 
Pseudomembranous candidiasis was found to be exclu-
sive to stage C disease with CD4 counts < 200 cells/
cu mm(p= 0.47).The frequency of oral lesions increased 
with lowering CD4 counts and the strongest association 
was with the prevalence of OC (p=0.012), PC (p=0.014) 
and OHL (p= 0.065). 
Oral candidiasis , the most common lesion in our stu-
dy (21%), was lower than previously recorded in India 
50.4%(1), 56%(9), 82%(11), 81%(12) and 32.25%(13). 
However, other Asian studies from Thailand 24.8 %( 8), 
Cambodia 22.8% (10) and Singapore 35%(14) showed 
similar prevalence. Of the oral candidiasis, erythema-
tous candidiasis (13 cases; 16%) was the most common 
followed by pseudomembranous candidiasis (4 cases; 
4.9%) and least by angular cheilitis (1 case; 1.2%). Sin-
ce a majority of our participants were in stage B clinical 
disease (mean CD4 count of 354.7 cells/cu mm) and the 
patients in stage C disease were receiving ARV therapy 
the above trends could be expected. It was interesting 
to note that PC was noted only in patients with CD4 
count < 200 cells/cu mm (p= 0.47). EC predominated in 
the stage B and stage C of clinical disease. No forms of 
candidiasis were detected in stage A clinical disease pa-
tients, clearly affirming the fact that candidiasis is a pro-
ven clinical marker for advanced immuno-suppression. 
Oral melanosis (17 cases;21%) was found to be the other 
most common lesion presenting as patchy brown areas 
over the labial, buccal and palatal mucosa. Nine patients; 
32.1 % on ARV presented with melanosis which was do-
uble in percentage terms, than the non-ARV group (8 
cases; 15.1%). Mixed prevalence has been reported from 
India of about 30% (13). Melanotic hyperpigmentation 
is well documented to be a side effect of HAART thera-
py (1).  However, we found no statistically significant 
difference in the distribution based on ARV therapy 
(p=0.73). Furthermore, tobacco smoking can cause gra-
yish pigmentation of the oral mucosa, but showed a poor 
association with the patchy brown pigmentation in our 
study(r=0.043, p=0.704). This suggests that ARV thera-
py and tobacco smoking may not be directly responsible 
for this peculiar pigmentation seen in HIV infection ad-
vocating the need for investigation in further studies.
Oral hairy leukoplakia seen in 10 patients (12.3%) was 
comparable to findings of other Asian studies 13% (8), 
13% (15) , 12%(16), and 11%(17), but slightly more 
Lesion Total Stage of disease λ
2 
Value sig
Spear-
man 
Rho 
value
sig CD4 Count SD
No(%) Stage ANo(%)
Stage B
No(%)
Stage C
No(%)
1. One lesion 31(38.3) 3(33.3) 16(41) 12(36.4) 4.449a .349 294.74 155.71
2. Multiple lesions 18(22.2) 0(0) 9(23.1) 9(27.3) 221.44 117.72
3. Oral Candidiasis 17(21) 2(22.2) 6(15.4) 9(27.3) 1.533a .465 0.012 245.0 163.4
4. Pseudomembranous Candidiasis 4(4.9) 0(0) 0(0) 4(12.1) 6.120a .047 -.272* .014 102.5 67.03
5. Erythematous  Candidiasis 13(16) 0(0) 8(20.5) 5(15.2) 2.317a .314 -.071 .528 254.0 112.3
6. Angular Cheilitis 1(1.2) 0(0) 1(2.6) 0(0) 1.090a .580 .000 1.000 293.0 -.
7. Oral hairy leukoplakia 10(12.3) 0(0) 4(10.3) 6(18.2) 2.464a .292 -.206 .065 193.9 120.0
8. Oral Warts 0(0) 0(0) 0(0) 0(0) - -
9. Herpes Labialis 6(7.4) 0(0) 4(10.3) 2(6.1) 1.269a .530 .038 .734 305.3 151.0
10. Herpetic Ulcers 0(0) 0(0) 0(0) 0(0) - -
11. LGE* 14(17.3) 0(0) 8(20.5) 6(18.2) 2.184a .336 -.147 .191 230.5 112.3
12. NUP/NUG* 7(8.6) 0(0) 3(7.7) 4(12.1) 1.402a .496 -.133 .235 215.8 155.8
13. Recurrent apthous ulcers 1(1.2) 0(0) 0(0) 1(3) 1.473a .479 -.067 .553 195.0 -
14. Ulcers NOS* 0(0) 0(0) 0(0) 0(0) - -
15. Melanosis 17(21) 2(22.2) 8(20.5) 7(21.2) .015a .993 .042 .709 294.6 139.8
16. Parotid gland enlargement 3(3.7) 1(11.1) 1(2.6) 1(3) 1.569a .456 .028 .804 481.5 164.7
17. Xerostomia 0(0) 0(0) 0(0) 0(0) - - - - - -
18. Kaposis sarcoma 0(0) 0(0) 0(0) 0(0) - - - - - -
19. Oral SCC* 0(0) 0(0) 0(0) 0(0) - - - - - -
20. Non Hodgkin’s
Lymphoma 0(0) 0(0) 0(0) 0(0) - - - - - -
*CD4 –[cluster of differentiation 4]- helper T lymphocyte, LGE- Linear Gingival Erythema,NUP/NUG- Necrotizing Ulcerative Perio-
dontitis/Necrotizing Ulcerative Gingivitis, Ulcers NOS- Ulcers Not Otherwise Specified, Oral SCC – Oral Squamous Cell Carcinoma
Table 3. Distribution of lesions by disease stage and association with CD 4 cell counts.
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than reported in Indian studies 3%(9), 2.1%(11), 7%(12), 
4.13%(13).
Fourteen cases; 17.3% of linear gingival erythema was 
the other common finding in a higher percentage of 
women (5 cases; 18.5%) as observed by Sharma et al. 
(25%)  (1). Necrotizing ulcerative gingivitis/periodonti-
tis (7 cases; 8.6%) was seen less frequently when com-
pared to studies from Cambodia 28 % (15)  and Thailand 
15 %( 18) but, more than reported from India 5.64 %( 
13). The recent inclusion of NUP and NUG as a single 
group in the revised case definitions has implications in 
the prevalence previously reported.  
Ulcerative lesions in HIV infection can be due to recu-
rrent apthous stomatitis (RAS), herpes simplex (HSV), 
cyto-megalo virus(CMV), varicella zoster virus(VZV) 
infections and necrotizing ulcerative stomatitis (NUS), 
while all other ulcerative lesions are recorded as ulcers 
not otherwise specified (NOS).  Six cases; 7.4% with 
herpes simplex lesions presenting as herpes labialis were 
recorded and treated with topical 5% acyclovir therapy. 
While oral herpes zoster lesions were absent; we howe-
ver, examined a case of cutaneous herpes zoster of the 
chest.  One case of recurrent apthous ulcers was noted in 
a male patient with CD4 count of 195cells/cu mm. Ul-
cerative lesions were an uncommon finding in our study. 
Since laboratory detection was not employed definitive 
diagnosis of the above mentioned ulcerative lesions was 
not possible. Hence, it may well be an incorrect estima-
tion of the true prevalence. 
Salivary gland disease (SGD) in HIV/AIDS includes xe-
rostomia and enlargement of salivary glands. We found 
three cases; 3.7% of bilateral parotid gland enlargement 
which was more than the 1% reported from Thailand 
(18).  Persistent circulating and visceral CD8 lympho-
cytic infiltration of parotid glands described as Diffuse 
Infiltrative Lymphocytic Syndrome (DILS) has been 
proposed to be the reason for the salivary gland enlar-
gement in HIV/AIDS(20).  Further, xerostomia has been 
shown to occur in patients with HAART (21), due to an 
antisecretory action on acinar cells. In our study all the 
three cases of salivary gland disease (SGD) manifesting 
as parotid enlargements were in patients not receiving 
ARV therapy while xerostomia was not recorded in any 
patient. Xerostomia has been reported from India at a 
prevalence of 16.12 %( 13).
Kaposi’s sarcoma has not been reported in other Asian 
studies. This has been explained due to the endemic ab-
sence of Human herpes Virus -8 in populations of these 
regions (21). Our sample size was insufficient to come 
across cases of non-Hodgkin’s Lymphoma (NHL) which 
usually has a low average prevalence of 3-5%.  Oral 
squamous cell carcinoma was similarly not recorded in 
any of the patients of the study.
ARV therapy was made available to 28 patients who re-
ceived highly active anti retro viral therapy (HAART), 
comprising either two Nucleoside Reverse Transcriptase 
Inhibitors (NRTI) + one Protease inhibitor (PI) or two 
NRTI + one Non-Nucleoside Reverse Transcriptase In-
hibitors (NNRTI). As a policy, HIV seropositive patients 
were monitored through regular checkups and instituted 
antibacterials, antifungals and vitamins. When patients 
showed rapid disease progression or were symptomatic 
with CD4 counts falling below 200 cells/cu mm HAART 
was initiated and maintained till CD4 counts stabilized. 
The true effects of HAART could not be estimated since 
treatment was initiated recently in a majority of patients. 
The majority of patients who were on HAART had been 
receiving treatment for a period of less than 6 months. 
Thereby, the lower average CD4 counts (190 cells/cu 
ml, SD 111.59) in the ARV group could be expected as a 
consequence. Recent guidelines of threshold CD4 counts 
for the initiation of HAART have been revised from 200 
to 350 cells/cu ml in mid and low-income countries (22). 
This may lead to a substantial increase in the number 
of patients who will be treated with HAART and the 
consequential change in the prevalence of oral lesions. 
The most common lesions in the ARV group were oral 
melanosis (9 cases; 32.1 %) and oral candidiasis, (9 ca-
ses; 32.1 %). In the patients not on ARV therapy erythe-
matous candidiasis, (9 cases; 17%) was frequently seen 
followed by melanosis, (8 cases; 15.1 %). All six cases; 
7.4% of herpes simplex lesion were seen in non - anti 
retro viral group (p=0.073) while oral candidiasis was 
commonly noted in the anti retro viral group (p=0.073).
Other oral lesions can occur due to deleterious habits 
in patients with HIV/AIDS; hence we further investiga-
ted tobacco and alcohol habits and their association to 
oral lesions. Leukoplakia (11 cases; 20.4%) and tobacco 
pouch keratoses (9 cases; 16.7%) were seen more fre-
quently in men. Tobacco consumption as khaini, gutka or 
cigarette was strongly associated with prevalence of leu-
koplakia (r=0.238, p=0.33) and tobacco pouch keratoses 
(r=0.265, p=0.017). Lichenoid lesions (3 cases; 3.7%) 
showed poor association with tobacco habits (r=0.139, 
p=.217). None of the oral lesions of HIV/AIDS showed 
a strong association with tobacco and alcohol habits.
This study is unique since the above findings haven’t 
yet been documented from this population. The present 
study shows a high prevalence of oral candidiasis, oral 
melanosis , LGE and OHL in the HIV infected patients. 
As in other parts of the world understanding the nature 
of the disease and its manifestations will lead to invol-
vement of all sections of the healthcare system including 
the dental profession which may largely have remained 
isolated here. 
The revised National Policy on HIV and STI, 2011 has 
highlighted a preventive approach for the National HIV/
AIDS Strategy for 2011-2016. Encouragingly, a signifi-
cant drop in HIV prevalence among injected drug users 
from 68% (2003 estimates) to 6.3 % (2011 estimates) 
e7
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has been observed. (5)
The national antiretroviral treatment programme has 
also received a boost as until  December 2011, 23.7 per 
cent (6,051 adults, 432 children) were accessing ARV 
therapy from 26 ARV treatment sites and 10 sub-ARV 
treatment sites throughout the country, a substantial ex-
pansion of ARV therapy sites from two at the start of 
2004 (5).  The role of the dental profession cannot be 
overstated in pitching in by early HIV/AIDS case iden-
tification and making a credible contribution to fighting 
this dreaded disease.  
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